Rimon Therapeutics :: Main Page

Main Page

Rimon Team

Conferences, Presentations and Posters

Technologies and Products

Markets and Opportunities

Media Kit

Photos

Rimon’s Holiday Lunch, 2008

HTX HealthTechnologyExchange

This Month

Month Archive

July 2009
June 2009
March 2009
October 2008
August 2008

Year Archive

2009
2008
2007
2006

Contact Information:

For More Information Contact: Rimon Therapeutics Limited 59 Adelaide St. East Suite 500 Toronto, Ontario Canada, M5C 1K6, 416-977-2003 (office), 416-977-6383 (fax), info@rimontherapeutics.com (email) or visit our website at: www.rimontherapeutics.com

Media Contact: Howard Oliver, What If What Next, 416-638-8582, holiver@whatifwhatnext.com.

Main Page

« Previous 30 days | Next 30 days »

Thursday, June 25

Coverage of Rimon Therapeutics in the Toronto Star

by Howard on Thu 25 Jun 2009 01:48 PM EDT

Groundbreaking health research gets boost

Province funnels $42M toward 15 projects, from medical plastics to early cancer detection
Jun 24, 2009 04:30 AM

By Megan Ogilvie Health Reporter

Plastics that heal tissue. Toronto researchers are working to quickly turn science fiction into reality in the marketplace. And yesterday, the province moved to speed up the research by funnelling $42 million toward 15 research projects in the city. The funds are part of a $91 million province-wide investment from the Ontario Research Fund and the Ontario Institute for Cancer Research. Recipients include:

Project: Therapeutic biomaterials for regenerative medicine
Lead institution: University of Toronto
Funding: $6.4 million

Therapeutic polymers, or Theramers, are medical plastics that act like drugs. They can be used to heal tissue, treat disease, induce the production of new blood vessels and kill bacteria.

Developed at the University of Toronto in conjunction with Rimon Therapeutics, a U of T spin-off company, the unique materials do not use or deliver drugs. This feature, which no other lab around the world is pursuing, makes Theramers "revolutionary," said Michael May, president of Rimon Therapeutics.

And, he added, since Theramers are medical devices, products will likely hit the market faster – some perhaps within four years – and may have fewer side effects than new drugs.

Researchers are investigating Theramers to treat eye disorders, periodontal disease, osteoarthritis, inflammatory bowel disease, reconstructive surgery and cardiovascular disease.

For more see: http://www.thestar.com/living/article/655635

Leave Comment | Permanent Link | Cosmos

Tuesday, June 23

Coverage of Rimon Therapeutics in Exchange

by Howard on Tue 23 Jun 2009 02:11 PM EDT

Revolutionary wound dressing will kick-start healing

When you cut your skin, the wound starts to repair itself almost immediately. But for chronic wounds the body needs more than a bandage to allow this healing process to begin.

In North America, millions of chronic wounds require constant care amounting to over $20 billion annually.

Toronto-based Rimon Therapeutics Ltd. has developed a “smart” dressing made from advanced medical polymers (plastics) that supports the body's natural healing process.

Rimon's MI-Sorb is an easy-to-apply dressing that contains the company's revolutionary bioactive materials called Theramers.

“Theramers allows the body to heal without the side effects or costs of conventional drugs,” said Michael May, President of Rimon.

The MI-Sorb dressing works by removing the tissue-destroying enzymes in chronic wounds (like diabetic ulcers or bedsores), kick-starting the natural healing process.

Developed from research at the University of Toronto, Rimon received its initial funding from Ontario Centres of Excellence (OCE) when co-founder Michael May was named the 1997 recipient of OCE's Martin Walmsley Fellowship for Technological Entrepreneurship.

OCE also worked to connect Rimon with world-class researchers, assisted with staff hiring and allowed the company to explore new technologies for licensing.

The first clinical trials of the MI-Sorb dressing have been completed, and Rimon plans to bring its product to market soon through a partnership with an established wound-care company. Future therapeutic applications include treating heart disease, delaying knee replacement and preventing medical device related infections.

For more see: http://www.exchangemagazine.com/morningpost/2009/week26/Tuesday/062311.htm

Leave Comment | Permanent Link | Cosmos

Friday, June 19

Coverage of Rimon Therapeutics on BNN

by Howard on Fri 19 Jun 2009 02:13 PM EDT

The Close : June 19, 2009 : NEXT: Bio Tech Bandages that Heal [06-19-09 4:20PM]

Rimon Therapeutics has developed a "smart" dressing for chronic wounds that actually kick-starts the healing process. The bio-tech company is teaming up with a wound-care company and hopes to bring its product to market soon. Future applications include treating heart disease, delaying knee replacement and preventing medical infections. BNN speaks to Michael May, president, Rimon Therapeutics.

For the video clip see: http://watch.bnn.ca/clip185002#clip185002

Leave Comment | Permanent Link | Cosmos